Chemoinformaics analysis of 6-Hexylsalicylic acid
Molecular Weight | 222.284 | nRot | 6 |
Heavy Atom Molecular Weight | 204.14 | nRig | 7 |
Exact Molecular Weight | 222.126 | nRing | 1 |
Solubility: LogS | -3.19 | nHRing | 0 |
Solubility: LogP | 4.36 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 36.1183 |
nHD | 2 | BPOL | 18.9257 |
QED | 0.726 |
Synth | 1.923 |
Natural Product Likeliness | 0.796 |
NR-PPAR-gamma | 0.929 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.002 |
HIA | 0.011 |
CACO-2 | -4.857 |
MDCK | 0.0000245 |
BBB | 0.23 |
PPB | 0.965055 |
VDSS | 0.202 |
FU | 0.0218229 |
CYP1A2-inh | 0.321 |
CYP1A2-sub | 0.386 |
CYP2c19-inh | 0.068 |
CYP2c19-sub | 0.062 |
CYP2c9-inh | 0.507 |
CYP2c9-sub | 0.244 |
CYP2d6-inh | 0.405 |
CYP2d6-sub | 0.131 |
CYP3a4-inh | 0.04 |
CYP3a4-sub | 0.049 |
CL | 1.554 |
T12 | 0.821 |
hERG | 0.124 |
Ames | 0.013 |
ROA | 0.183 |
SkinSen | 0.253 |
Carcinogencity | 0.081 |
EI | 0.98 |
Respiratory | 0.711 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.591322 |